MUCOLYTIC THERAPY IN PEDIATRICS: MYTHS AND REALITY
The article highlights the treatment of the respiratory tract diseases accompanied by the development of mucostasis and dyscrinia among children. The author described the mucolytic therapy thoroughly by the original medication from the N_acetylcysteine group, which has both mucolytic and antioxidant...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2009-04-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The article highlights the treatment of the respiratory tract diseases accompanied by the development of mucostasis and dyscrinia among children. The author described the mucolytic therapy thoroughly by the original medication from the N_acetylcysteine group, which has both mucolytic and antioxidant and antiinflammatory effects. These properties are more important in the event of the chronic bronchopul-monary pathology and explain its high efficiency. Different dosage forms allow the doctor to apply a medication among patients of various age, including neonates and infants.Key words: respiratory tract diseases, mucostasis, dyscrinia, mucolytic therapy, children. |
|---|---|
| ISSN: | 1727-5776 2500-3089 |